SpringWorks Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

STAMFORD, Conn., Oct. 22, 2024 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, November 12, 2024 to report its third quarter financial results and discuss recent business updates.

To join the live webcast and view the corresponding slides, please click here. To participate in the live conference call by phone, please click here to pre-register. Registered participants will then be provided with a dial-in number and conference code to access the call. A replay of the webcast will be available for a limited time following the event on the Investors & Media section of the Company’s website at https://ir.springworkstx.com.

About SpringWorks Therapeutics

SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. OGSIVEO® (nirogacestat), approved in the United States for the treatment of adult patients with progressing desmoid tumors who require systemic treatment, is the Company’s first FDA-approved therapy. SpringWorks also has a diversified targeted therapy pipeline spanning solid tumors and hematological cancers, with programs ranging from preclinical development through advanced clinical trials. In addition to its wholly owned programs, SpringWorks has also entered into multiple collaborations with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients in need.

For more information, visit www.springworkstx.com and follow @SpringWorksTx on X (formerly Twitter), LinkedIn, and YouTube.

Contacts:
Investors
investors@springworkstx.com

Media
media@springworkstx.com

Staff

Recent Posts

Flosonics Medical Earns Best In Class Digital Health Award for World’s First Wearable Doppler Ultrasound Patch

LAS VEGAS--(BUSINESS WIRE)--#criticalcare--Flosonics Medical, a leader in wearable medical ultrasound, was selected as a Best…

23 mins ago

BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results

Management Guides Fourth Quarter Revenues to Grow to at Least $7.2 Million USD; Reaffirms Goal…

28 mins ago

Xcelerate, Inc. Announces the Launch of the Ceramedx Tik Tok Skincare Campaign

MAULDIN, SC / ACCESSWIRE / October 23, 2024 / Xcelerate, Inc. (OTCQB:XCRT) today announced that…

28 mins ago

Triple Board-Certified Surgeon and Hair Transplant Expert Dr. Jason Dudas Joins the Aesthetic Surgery Center in Naples, FL

Leading hair transplant surgeon Dr. Jason Dudas brings cutting-edge techniques to Naples.NAPLES, FL / ACCESSWIRE…

28 mins ago

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors

– Preclinical data demonstrate that inhibiting the p300 KAT domain reactivates p53 in HPV-driven tumors…

28 mins ago